Initiatives

In Safe Patient Care

New Monitoring Strategies to Improve Outcomes

Processed EEG Monitoring:
The Use of TIVA in Enhanced
Recovery

 

Date:

May 15, 2019 @12 PM ET

 

Speaker:

 TJ Gan, MD, MBA MHS, FRCA

Department of Anesthesiology

Stony Brook University Renaissance

School of Medicine

Stony Brook, NY

Respiratory Compromise:
Risk Prediction on the General
Care Floor

 

 

Date:

May 29, 2019 @12 PM ET

 

Speakers:

Frank Overdyk, MSEE, MD

Trident Anesthesia Associates

Charleston, SC

 

Ashish Khanna, MD, FCCP

Wake Forest University
School of Medicine,

Winston-Salem, NC.

 

Description:

Enhanced recovery after surgery (ERAS) has demonstrated to improve outcomes. This webinar discusses the advantages of ERAS in managing surgical patients and identifies the various elements of enhanced recovery pathways. The role of processed EEG monitoring in intra-operative anesthetic management and the application of neuromonitoring in improving postoperative outcomes in patients undergoingtotal intravenous anesthesia will also be discussed.

 

# Varandhan KK et al. The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: A meta-analysis of randomized controlled trials. Clin. Nutr 2010 + Overdyk FJ, Carter R, Maddox RR, Callura J, Herrin AE, Henriquez C.

 

 

 

Learning Objectives

Upon completion of this activity, the participant will be able to:

  1. Describe the objectives of enhanced recovery strategy
  2. Discuss the use of total intravenous anesthesia (TIVA) in enhanced recovery
  3. Assess the value of processed EEG when using TIVA

 

Bio:

T.J. Gan, MD is Professor and Chairman of The Department of Anesthesiology at Stony Brook University, NY. Dr. Gan is the past-president of the Society for Ambulatory Anesthesia and the International Society of Anesthetic Pharmacology. He serves on several editorial boards including of Anesthesia and Analgesia and Perioperative Medicine to name a few. He has published more than 200 peer-review publications and is considered a world expert on postoperative nausea and vomiting and acute pain. He also has a major interest in Enhanced Recovery After Surgery (ERAS) Program for improving postoperative outcome of surgical patients.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Description:

Opioid-induced respiratory depression (OIRD), a form of respiratory compromise, is one of the leading avoidable patient safety issue. Respiratory compromise, increases morbidity and mortality as well hospital inpatient costs. This presentation will discuss the results of a recent, multi-center study PRODIGY designed to identify people at high risk for OIRD. Results showed that more than 40% of patients on the general care floor experienced OIRD. The investigators will share an easy-to-use risk prediction tool they developed to identify patients at high risk that can lead to earlier interventions.

 

#  Continuous oximetry/capnometry monitoring reveals frequent desaturation and bradypnea during patient-controlled analgesia. Anesth Analg.2007;105(2):412–418.

 

Learning Objectives

Upon completion of this activity, the participant will be able to:

  1. Discuss current recommendations regarding vital sign surveillance by patient safety and regulatory organizations
  2. Describe implementation strategy for continuous respiratory monitoring

 

Bio:

Frank Overdyk, MSEE, MD. Dr. Overdyk is a Professor of Anesthesiology with an expertise in opioid pharmacology and respiratory depression. He has lectured extensively on this topic as well as patient safety indices, and his passion is to reduce preventable harm from late detection of respiratory compromise of all etiologies, through continuous monitoring of vital signs.

 

Ashish K. Khanna, MD, FCCP. Dr. Khanna is anesthesiologist and intensivist at the Wake Forest University School of Medicine, Winston-Salem, NC. Dr. Khanna serves on the editorial boards including the Journal of Anesthesiology. He has published extensively in peer-reviewed journals on several perioperative topics including opioid-related respiratory complications.

Continuing Education for Physicians, Nurse Anesthetists, Nurses and Respiratory Therapists

This program has been approved for 1.0 contact hour. SynAptiv is accredited by the Accreditation Council for Continuing

Medical Education (ACCME) for 1 AMA PRA Category 1 Credit.

This program has been prior approved by the American Association of Nurse Anesthetists for 1.0 Class A CE Credits.

Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving, TX 75063.

This education activity is approved for 1.0 contact hour. Provider approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032

Support for this educational activity from Medtronic